Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Index funds are priced at the end of the trading day based on net asset value and intraday adjustments. This intro explains the timing and what to watch.
15,016 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Two popular short-term bond ETFs—VCSH and ISTB—offer different paths to steady income. This guide breaks down cost, r...
A major fund recently moved a sizable chunk of Osisko Development shares, prompting questions about what it means for...
Some ETFs have consistently outpaced the S&P 500 over long stretches. This guide breaks down what that means, the ris...
Starting to invest can feel overwhelming. This guide helps you understand risk tolerance and build your first portfol...
Lynx Investment Advisory recently disclosed a meaningful stake in the Akre Focus ETF, signaling confidence in a quali...
A seasoned financial planner argues that a two-ETF approach can cover most retirement needs, pairing a dividend-based...
Is there a smarter way to diversify beyond the U.S.? This article explores whether could this international best ETF ...
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...
When a major holder severs a stake in a big airline, it signals shifts in sentiment. We break down what cobalt capita...
Rumors spread quickly, but your finances shouldn’t. This guide uses the phrase 'oliver tree reportedly dies' to explo...